Login / Signup

In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii.

Nazanin PouyaJames E SmithCole S HudsonNicholas S TeranVincent H Tam
Published in: Journal of global antimicrobial resistance (2024)
Using multiple AVI concentrations within the clinically relevant range, our susceptibility testing approach could have better insights of treatment outcome for infections caused by CRAB. This could potentially lead to effective intervention(s) overlooked by conventional susceptibility testing method. This case highlights the importance of site-specific drug exposures on determining treatment outcome.
Keyphrases